The US Food and Drug Administration (FDA) has cleared the first AI-powered handheld medical device to assist physicians in detecting common skin cancers.
City of Hope researchers discover human ILC2s and immune cells, exhibit unprecedented cancer-killing abilities, challenge assumptions, and offer a versatile, off-the-shelf approach to revolutionize cancer immunotherapy.